WHO pilot study on the validity of imipramine platelet receptor binding sites as a biological marker of endogenous depression. A preliminary report on the initial evaluation phase of a World Health Organization Collaborative Study.
Bech
P
P
Frederiksborg General Hospital, Hillerød, Denmark.
Eplov
L
L
Gastpar
M
M
Gentsch
C
C
Mendlewicz
J
J
Plenge
P
P
Rielaert
C
C
Mellerup
E T
ET
D001792:Blood Platelets / Q000378:metabolism*; D002352:Carrier Proteins; D003866:Depressive Disorder / Q000097:blood*; D006801:Humans; D007099:Imipramine / Q000493:pharmacokinetics*; D011869:Radioligand Assay; D011955:Receptors, Drug; D017981:Receptors, Neurotransmitter / Q000378:metabolism*
D002352:Carrier Proteins; D011955:Receptors, Drug; D017981:Receptors, Neurotransmitter; C027775:imipramine receptor; D007099:Imipramine